Using genetic engineering, scientists are transforming plants into biological factories. Chloroplasts already produce the oxygen we breathe — could they produce medicine, too?
Electrical engineer Amit Roy-Chowdhury has teamed up with art historian Conrad Rudolf to identify unknown portrait subjects.
Social media may be psychologists and researchers’ newest tool to analyze the human mind. Researchers at the University of Pennsylvania and the University of Vermont are using data from Facebook and Twitter to learn about our thoughts and emotions.
The Strittmatter Lab has uncovered the hidden protein that serves as the intermediary in the downward spiral towards Alzheimer’s disease; this protein is the target for one of the most innovative drug interventions to date.
Biotechnology companies are the stepping-stones between university research and its development into drugs that cure people. But the road from research to drug is difficult and risky, and not every company can make it.
Yale researchers Professor Mark Gerstein and Dr. Ekta Khurana have led an investigation into non-coding regions of DNA resulting in the identification of cancer triggers for further characterization. Their process can be generalized to uncover triggers for other diseases, and these triggers could be potential targets for therapeutics and precision medicine.
Bacteria all around us produce an endless variety of bioactive small molecules. Yale Chemistry Professor, Jason Crawford, has harnessed rapid sequencing technology to mine the bacterial genome in search of novel natural products for drug development.
A recent study from the lab of Antonio Giraldez, Associate Professor of Genetics, has identified three critical transcription factors controlling the maternal to zygotic transition in early embryonic development.
Saving water in the Serengeti: In ENAS 118: Introduction to Innovation, Engineering and Design, students designed water quality monitoring technology that could benefit millions in the Mara River Basin.
A Yale-led study has found that SIV, which causes AIDS in various non-human primates, leads to disruption of gut microbiome that may give rise to many of the deadly infections that compromise host health.